Answer
Angioedema is classified as rare with linagliptin, affecting at least 1 in 10,000 but fewer than 1 in 1,000 patients, based on post-marketing experience.
Sources for this answer
- Linagliptin 5 mg film-coated tablets (previously known as Trajenta)Boehringer Ingelheim Limited · emc · SmPC §4.8 Undesirable effects · Version 19Document updated
Sources checked